Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Foresee Genomics Ltd. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution landscape for this company is very narrow, featuring 1 distinct examiner and 1 distinct art unit. This suggests that the company's current patent applications are focused on a specific genomic or biotechnological advancement that falls under a single area of expertise at the patent office.
The busiest examiner is GREENE, CAROLYN LEE, who is responsible for 1 busiest examiner pending office action. This 1 examiner manages the entirety of the company's current pending workload, making their individual examination practices the primary concern for the company's legal representatives. With only 1 distinct art unit involved, there is no variation in the technical standards being applied to the portfolio, which provides a consistent environment for prosecution.
The prosecution strategy is centered on the 1 pending office action, and the outcome depends heavily on the dialogue with GREENE, CAROLYN LEE. Practitioners should analyze the examiner's past actions in the Biotechnology & Pharmaceuticals field to identify successful negotiation tactics. Efficiently addressing the concerns raised in the 1 pending office action will be the most direct way to secure the company's patent rights.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GREENE, CAROLYN LEE | 1 | 65.3% | +47.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17293085 | MULTIMER FOR SEQUENCING AND METHODS FOR PREPARING AND ANALYZING THE SAME | GREENE, CAROLYN LEE | 20d |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17293085 | MULTIMER FOR SEQUENCING AND METHODS FOR PREPARING AND ANALYZING THE SAME | GREENE, CAROLYN LEE | 1681 | §103 | Final Rejection | 20d | Pending | May 12, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial